Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melvyn T Chow

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Immunology Research|December 7, 2014
Chemokines in cancerMelvyn T Chow, Andrew D Luster
Seminars in Cancer Biology|January 3, 2012
Inflammation and immune surveillance in cancerMelvyn T Chow, Andreas Möller, Mark J Smyth
Immunity|April 11, 2021
Chemokines and the immune response to cancerAleksandra J Ozga, Melvyn T Chow, Andrew D Luster
Immunology and Cell Biology|September 27, 2012
NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesotheliomaMelvyn T Chow, Jürg Tschopp, Andreas Möller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2012
Role of γδ T cells in α-galactosylceramide-mediated immunityChristophe Paget, Melvyn T Chow, Helene Duret, et al.
European Journal of Immunology|April 2, 2014
Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome primingMelvyn T Chow, Helene Duret, Daniel M Andrews, et al.
Oncoimmunology|September 26, 2015
Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasisCamille Guillerey, Melvyn T Chow, Kim Miles, et al.
Cancer Research|September 19, 2012
NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastasesMelvyn T Chow, Jaclyn Sceneay, Christophe Paget, et al.
Immunity|November 30, 2021
CXCL10 chemokine regulates heterogeneity of the CD8<sup>+</sup> T cell response and viral set point during chronic infectionAleksandra J Ozga, Melvyn T Chow, Mateus E Lopes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2013
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsPaul A Beavis, Upulie Divisekera, Christophe Paget, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Immunology Research|December 7, 2014
Chemokines in cancerMelvyn T Chow, Andrew D Luster
Seminars in Cancer Biology|January 3, 2012
Inflammation and immune surveillance in cancerMelvyn T Chow, Andreas Möller, Mark J Smyth
Immunity|April 11, 2021
Chemokines and the immune response to cancerAleksandra J Ozga, Melvyn T Chow, Andrew D Luster
Immunology and Cell Biology|September 27, 2012
NLRP3 promotes inflammation-induced skin cancer but is dispensable for asbestos-induced mesotheliomaMelvyn T Chow, Jürg Tschopp, Andreas Möller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2012
Role of γδ T cells in α-galactosylceramide-mediated immunityChristophe Paget, Melvyn T Chow, Helene Duret, et al.
European Journal of Immunology|April 2, 2014
Type I NKT-cell-mediated TNF-α is a positive regulator of NLRP3 inflammasome primingMelvyn T Chow, Helene Duret, Daniel M Andrews, et al.
Oncoimmunology|September 26, 2015
Toll-like receptor 3 regulates NK cell responses to cytokines and controls experimental metastasisCamille Guillerey, Melvyn T Chow, Kim Miles, et al.
Cancer Research|September 19, 2012
NLRP3 suppresses NK cell-mediated responses to carcinogen-induced tumors and metastasesMelvyn T Chow, Jaclyn Sceneay, Christophe Paget, et al.
Immunity|November 30, 2021
CXCL10 chemokine regulates heterogeneity of the CD8<sup>+</sup> T cell response and viral set point during chronic infectionAleksandra J Ozga, Melvyn T Chow, Mateus E Lopes, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2013
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsPaul A Beavis, Upulie Divisekera, Christophe Paget, et al.
Pageof 2